Cytek BioSciences, Inc. Contracts & Agreements
24 Contracts & Agreements
- Business Finance (4 contracts)
- Business Operations (3)
- Human Resources (8)
- Intellectual Property (1)
- Real Estate (2)
- Uncategorized (6)
- Offer letter, by and between Cytek Biosciences, Inc. and Allen Poirson, Ph.D., dated March 23, 2021 (Filed With SEC on May 8, 2024)
- Cytek Bioscience, Inc (Filed With SEC on May 8, 2024)
- Offer Letter between William McCombe and the Company dated February 22, 2024, as amended by the Amendment dated March 18, 2024 (Filed With SEC on March 19, 2024)
- Forms of Restricted Stock Unit Grant Notice and Restricted Stock Unit Award Agreement under the 2021 Equity Incentive Plan, effective August 23, 2022 (Filed With SEC on November 9, 2022)
- Forms of Option Agreement and Notice of Stock Option Grant under 2021 Equity Incentive Plan, effective August 23, 2022 (Filed With SEC on November 9, 2022)
- Offer Letter dated October 4, 2022, between Chris Williams and the Company (Filed With SEC on November 1, 2022)
- Description of Securities (Filed With SEC on March 17, 2022)
- Forms of Restricted Stock Unit Grant Notice and Restricted Stock Unit Award Agreement under the 2021 Equity Incentive Plan (Filed With SEC on November 12, 2021)
- Supply Agreement between the Registrant and Cytek (Wuxi) Biosciences Co., Ltd, a China subsidiary of Cytek Biosciences, Inc., and Coherent NA, Inc. dated August 25, 2021 (Filed With SEC on November 12, 2021)
- Cytek Biosciences, Inc. 2021 Employee Stock Purchase Plan (Filed With SEC on July 19, 2021)
- Cytek Biosciences, Inc. Amended and Restated Severance Benefit Plan (Filed With SEC on July 19, 2021)
- Form of Indemnification Agreement, by and between Cytek Biosciences, Inc. and each of its directors and executive officers (Filed With SEC on July 19, 2021)
- Forms of Option Agreement and Notice of Stock Option Grant under 2021 Equity Incentive Plan (Filed With SEC on July 19, 2021)
- Cytek Biosciences, Inc. 2021 Equity Incentive Plan (Filed With SEC on July 19, 2021)
- Form of common stock certificate of Cytek Biosciences, Inc (Filed With SEC on July 19, 2021)
- Form of Underwriting Agreement (Filed With SEC on July 19, 2021)
- Amended and Restated Investors Rights Agreement, by and among Cytek Biosciences, Inc. and certain of its stockholders, dated October 23, 2020 (Filed With SEC on July 2, 2021)
- Lease, by and between SNH Medical Office Properties Trust and Cytek Biosciences, Inc., dated November 20, 2020 (Filed With SEC on July 2, 2021)
- Lease, by and between Crest Properties LLC and Cytek Biosciences, Inc., dated as of July 24, 2015 (Filed With SEC on July 2, 2021)
- Settlement, License, and Equity Issuance Agreement, by and between Becton, Dickinson and Company and Cytek Biosciences, Inc., dated October 5, 2020 (Filed With SEC on July 2, 2021)
- Supply and License Agreement, by and between Biotium, Inc. and Cytek Biosciences, Inc., dated as of September 1, 2020 (Filed With SEC on July 2, 2021)
- Offer letter, by and between Cytek Biosciences, Inc. and Patrik Jeanmonod, dated October 5, 2018 (Filed With SEC on July 2, 2021)
- Forms of Option Agreement, Notice of Stock Option Grant and Exercise Notice under Cytek Biosciences, Inc. 2015 Equity Incentive Plan (Filed With SEC on July 2, 2021)
- Cytek Biosciences, Inc. 2015 Equity Incentive Plan, as amended (Filed With SEC on July 2, 2021)
